Target intelligence / Profile preview

Serum albumin (ALB) and Beta-lactoglobulin (LGB) (ALB/BLG)

Target
ALB/BLG
Molecular classification
Transporter, Lipocalin, Plasma protein
01

Overview

Serum albumin is the most abundant protein in mammalian plasma, synthesized by the liver, and is essential for maintaining colloid osmotic pressure and transporting various ligands such as fatty acids, hormones, and drugs [UniProt P02768]. Beta-lactoglobulin is the major whey protein in the milk of ruminants and other species, belonging to the lipocalin family, but it is notably absent in human milk [UniProt P02754]. While serum albumin is used clinically for volume expansion and as a drug delivery vehicle to enhance the pharmacokinetics of agents like paclitaxel, beta-lactoglobulin is primarily recognized as a major food allergen [StatPearls, Albumin; PubMed PMID: 26044860]. The binding of drugs to serum albumin significantly influences their distribution and free plasma concentration, which is a critical factor in pharmacological dosing [Peters, T., All About Albumin, 1995]. This target entry is considered complex as it combines a vital human transport protein with a non-human milk protein, both of which have distinct biological roles and medical implications [PubChem, Beta-lactoglobulin].

Other names
HSAALBLGBBeta-LGHuman serum albuminBovine beta-lactoglobulinWhey protein
02

Mechanism of action

Serum albumin functions as a carrier protein that non-covalently binds and transports hydrophobic molecules in the blood, while beta-lactoglobulin acts as a lipocalin-family transporter in milk and serves as a primary antigen in milk allergies.

03

Biological functions

TransportMaintenance of colloid osmotic pressureLigand bindingNutrient delivery
04

Disease associations

HypoalbuminemiaLiver cirrhosisNephrotic syndromeFood allergyInflammation
05

Safety considerations

Anaphylaxis in milk-allergic individualsFluid overload and pulmonary edemaAltered drug free-fraction in hypoalbuminemia
06

Interacting drugs

Warfarin

5 more in the full profile.

07

Biomarkers

Serum albumin levelsBeta-lactoglobulin-specific IgE antibodiesUrine albumin-to-creatinine ratio

Beyond the preview

Go deeper on Serum albumin (ALB) and Beta-lactoglobulin (LGB) (ALB/BLG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum albumin (ALB) and Beta-lactoglobulin (LGB) (ALB/BLG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call